![](/images/graphics-bg.png)
Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist
Joint Authors
DiSaia, Philip John
duPont, Nefertiti Chianti
Source
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-05-17
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Endometrial stromal sarcoma (ESS) formerly classified as low-grade endometrial stromal sarcoma is a rare uterine malignancy with a good prognosis despite a tendency to recur.
Primary surgical management for ESS includes total abdominal hysterectomy and bilateral salpingo-oophorectomy.
Patients with ESS have long disease-free survival rates when treated with primary surgical therapy, but nearly fifty percent of these patients will recur.
We present the case of a patient with recurrent ESS who had an excellent response to combined therapy with megestrol and leuprolide.
American Psychological Association (APA)
duPont, Nefertiti Chianti& DiSaia, Philip John. 2010. Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist. Complexity،Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-989728
Modern Language Association (MLA)
duPont, Nefertiti Chianti& DiSaia, Philip John. Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist. Complexity No. 2010 (2010), pp.1-3.
https://search.emarefa.net/detail/BIM-989728
American Medical Association (AMA)
duPont, Nefertiti Chianti& DiSaia, Philip John. Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist. Complexity. 2010. Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-989728
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-989728